Stelmakh Edward — SEC Form 4 filings
SEC reporting owner CIK 1887046. 16 Form 4 filings on record with FilingPulse; latest filed 2026-08-24.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-02-21 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 1,388 shares, $18,752 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 30.
- Largest priced transaction: sale of 1,388 shares @ $13.51 ($18,752) in OptimizeRx Corp, filed 2025-12-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| OptimizeRx Corp (OPRX) | Chief Finance & Strat Officer | 16 | — | 1 leg · 1,388 sh · $18,752 | 30 |
Form 4 filings — Stelmakh Edward
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-24 | 4 | OptimizeRx Corp (OPRX) | Tax withholding (F): 1,381 @ $7.71 | EDGAR |
| 2025-12-23 | 4/A | OptimizeRx Corp (OPRX) | Option exercise (M): 5,237 @ $0 · Tax withholding (F): 1,388 @ $13.51 · Option exercise (M): 5,237 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | OptimizeRx Corp (OPRX) | Tax withholding (F): 3,658 @ $12.74 | EDGAR |
| 2025-12-22 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 5,237 @ $0 · Sale (S): 1,388 @ $13.51 · Option exercise (M): 5,237 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 16,623 @ $0 · Tax withholding (F): 4,406 @ $18.75 · Option exercise (M): 16,623 (derivative) @ $0 | EDGAR |
| 2025-08-25 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 15,625 @ $0 · Grant/award (A): 35,156 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | OptimizeRx Corp (OPRX) | Tax withholding (F): 2,156 @ $6.64 | EDGAR |
| 2024-12-27 | 4/A | OptimizeRx Corp (OPRX) | Grant/award (A): 0 @ $0 | EDGAR |
| 2024-12-27 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 41,408 @ $0 · Grant/award (A): 77,742 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 5,237 @ $0 · Tax withholding (F): 1,316 @ $4.75 · Option exercise (M): 5,237 (derivative) @ $0 | EDGAR |
| 2024-10-15 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 8,222 @ $0 · Tax withholding (F): 2,066 @ $6.63 · Option exercise (M): 8,222 (derivative) @ $0 | EDGAR |
| 2024-10-07 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 16,622 @ $0 · Tax withholding (F): 4,177 @ $7.83 · Option exercise (M): 16,622 (derivative) @ $0 | EDGAR |
| 2024-04-24 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 7,083 @ $0 | EDGAR |
| 2024-04-22 | 4/A | OptimizeRx Corp (OPRX) | Tax withholding (F): 3,539 @ $15.17 | EDGAR |
| 2024-04-22 | 4/A | OptimizeRx Corp (OPRX) | Option exercise (M): 8,221 @ $0 | EDGAR |
| 2024-02-21 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 15,711 (derivative) @ $0 · Grant/award (A): 15,711 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1887046 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →